The effect of fentanyl on electrophysiologic recovery of CA 1 pyramidal cells from anoxia in the rat hippocampal slice

Anesthesia and Analgesia

Volumn 87, Issue 1, 1998, Pages 68-71

  Charchaflieh, Jean ^a,b   Cottrell, James E ^a   Kass, Ira S ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL;

ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ANALGESICS, OPIOID; ANESTHETICS, INTRAVENOUS; ANIMALS; CELL HYPOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FENTANYL; MALE; NEURONS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031863594     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199807000-00015     Document Type: Article

References (29)

1. Shibata S, Tominaga K, Watanabe S. Kappa opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats. Eur J Pharmacol 1995;279: 197-202.
2. Bofetiado DM, Mayfield KP, D'Alecy LG. Alkaloid delta agonist BW373U86 increases hypoxic tolerance. Anesth Analg 1996;82: 1237-41.
3. Deleted in proof.
4. Holaday JW, D'Amato RJ. Naloxone or TRH fails to improve neurologic deficits in gerbil models of "stroke." Life Sci 1982; 31:385-92.
5. Deleted in proof.
6. Morimoto Y, Morimoto Y, Bart RD, et al. High-dose fentanyl does not adversely affect outcome from forebrain ischemia in the rat. J Neurosurg Anesth 1997;9:316-23.
7. Perry DC, Getz R, Lee IY, et al. Forebrain ischemia in the gerbil increase lambda opiate binding in hippocampal mossy fibers. Brain Res 1993;617:296-302.
8. Iwai T, Masayuki N, Nakashima M, et al. Effect of opioids on delayed neuronal death in the gerbil hippocampus. Life Sci 1992;50:239-44.
9. Levy RM, Stryker M, Hosobuchi Y. Studies of nuclear magnetic resonance imaging and regional cerebral glucose metabolism in acute cerebral ischemia: possible mechanism of opiate antagonist therapeutic activity. Life Sci 1983;33(Suppl 1):763-8.
10. Kass IS, Lipton P. Protection of hippocampal slices from young rats against anoxic transmission damage is due to better maintenance of ATP. J Physiol 1989;413:1-11.
11. Stengaard-Pederson K. Comparative mapping of opioid receptors and enkephalin immunoreactive nerve terminals in the rat hippocampus. Histochemistry 1983;79:311-33.
12. Smith ML, Auer RN, Siesjo BK. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol (Berl) 1984;64:319-32.
13. Rao TLK, Mummaneni N, El-Etr AA. Convulsions: an unusual response to intravenous fentanyl administration. Anesth Analg 1982;61:1020-1.
14. Wynands JE, Wong P, Townsend GE, et al. Narcotic requirements for intravenous anesthesia. Anesth Analg 1984;63:101-5.
15. Schleimer R, Benjamini E, Eisele J, Henderson G. Pharmacokinetics of fentanyl as determined by radioimmunoassay. Clin Pharmcol Ther 1978;23:188-94.
16. Ruzicka BB, Fox CA, Thompson RC, et al. Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Mol Brain Res 1995;34:209-20.
17. Samra SK, Lilly DJ, Rush N, Kirsh MM. Fentanyl anesthesia an human brain-stem auditory evoked potentials. Anesthesiology 1984;61:261-5.
18. Loughnan BL, Sebel PS, Thomas D, et al. Evoked potentials following diazepam or fentanyl. Anaesthesia 1987;42:195-8.
19. McPherson RW, Sell B, Traystman RJ. Effects of thiopental, fentanyl, and etomidate on upper extremity somatosensory evoked potentials in humans. Anesthesiology 1986;65:584-9.
20. Pathak KS, Brown RH, Cascorbi HF, et al. Effects of fentanyl and morphine on intraoperative somatosensory cortical-evoked potentials. Anesth Analg 1984;63:833-7.
21. Choi DW, Viseskul V. Opioids and non-opioid enantiomers selectively attenuate Nmethyl-D-aspartate neurotoxicity on cortical neurons. Eur J Pharmacol 1988;155:27-35.
22. Przewlocka B, Machelska H, van Luijtelaar G, et al. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats. Neurosci Lett 1995;186:131-4.
23. George SR, Zastawny RL, Briones-Urbina R, et al. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Commun 1994;205:1438-44.
24. Mansour A, Fox CA, Burke S, et al. Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybrid-ization study. J Comp Neurol 1994;350:412-38.
25. Ofri D, Fan L, Simon EJ, Hiller JM. Lesioning of the nucleus basalis of Meynert has differential effects on mu, delta and kappa opioid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res 1992;581:252-60.
26. Scavini C, Rozza A, Bo P, et al. Kappa-opioid receptor changes and neurophysiological alterations during cerebral ischemia in rabbits. Stroke 1990;21:943-7.
27. Freid R, Nowark TS Jr. Opioid peptide levels in gerbil brain after transient ischemia: lasting depletion of hippocampal dynorphin. Stroke 1987;18:765-70.
28. Tamura T, Taniguchi T, Miyamoto T, et al. Protective effects of eptazocin, a novel analgesic against cerebral ischemia in mice and rats. Folia Pharmacol Jpn 1991;97:65-74.
29. Furui T. Potential protection by a specific kappa-opiate agonist U-50488H against membrane failure in acute ischemic brain. Neurol Med Chir 1993;33:133-8.